
Download the app to access in-depth Shariah compliance reports for over 60,000 global stocks.
Get the App
Rocket One Inc. is a U.S.-based clinical-stage pharmaceutical company focused on developing novel therapies for dermatological and related conditions. Its pipeline includes investigational treatments for eczema, psoriasis, acne, chronic wounds, and asthma, with a core asset being the BioLexa Platform, a proprietary drug compound system designed to treat eczema. The company operates primarily out of New Jersey.